Pieris Pharmaceuticals logo
Pieris Pharmaceuticals PIRS
$ 16.6 4.18%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Pieris Pharmaceuticals Cash and Cash Equivalents 2011-2024 | PIRS

Annual Cash and Cash Equivalents Pieris Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
17.4 M 38.6 M 118 M 70.4 M 62.3 M 74.9 M 37.9 M 29.4 M 29.3 M 18.5 M 3.69 M - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
118 M 3.69 M 45.5 M

Quarterly Cash and Cash Equivalents Pieris Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
19.4 M 19.7 M 19.1 M 17.4 M 32.9 M 44.9 M - 38.6 M 48.4 M - 83.7 M 118 M 125 M 119 M 66.8 M 70.4 M 70.4 M 70.4 M 70.4 M 62.3 M 62.3 M 62.3 M 62.3 M 74.9 M 74.9 M 74.9 M 74.9 M 37.9 M 37.9 M 37.9 M 37.9 M 29.4 M 29.4 M 29.4 M 29.4 M 29.4 M 29.3 M 29.3 M 29.3 M 18.5 M 18.5 M 18.5 M 18.5 M 3.69 M 90 90 - 6.33 M - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
125 M 90 45.6 M